ELYM
Income statement / Annual
Last year (2023), Eliem Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Eliem Therapeutics, Inc.'s net income was -$35.12 M.
See Eliem Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$15.41 M
|
$26.21 M
|
$23.32 M
|
$9.34 M
|
$4.02 M
|
| General & Administrative
Expenses |
$9.89 M
|
$18.92 M
|
$12.35 M
|
$2.43 M
|
$677,000.00
|
| Selling & Marketing
Expenses |
$24.85 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$9.89 M
|
$18.92 M
|
$12.35 M
|
$2.43 M
|
$677,000.00
|
| Other Expenses |
$0.00 |
$1.38 M |
-$11.64 M |
$0.00 |
$914,000.00 |
| Operating Expenses |
$37.41 M |
$45.14 M |
$35.67 M |
$11.77 M |
$4.70 M |
| Cost And Expenses |
$37.41 M |
$45.14 M |
$35.67 M |
$11.77 M |
$4.70 M |
| Interest Income |
$0.00 |
$1,198.00 |
$450.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$1.59 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$21.47 M
|
$45.14 M
|
$35.67 M
|
$11.77 M
|
$4.70 M
|
| EBITDA |
-$13.65 M
|
-$43.65 M
|
-$35.50 M
|
-$2.87 M
|
-$1.93 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$13.65 M
|
-$109,000.00
|
-$11.81 M
|
$257,000.00
|
$899,000.00
|
| Income Before Tax |
-$35.12 M |
-$45.24 M |
-$47.48 M |
-$20.67 M |
-$6.55 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$21,466.00 |
$109,000.00 |
-$66,558.00 |
-$9.16 M |
-$2.75 M |
| Net Income |
-$35.12 M |
-$45.35 M |
-$47.48 M |
-$11.51 M |
-$3.80 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.3 |
-1.72 |
-1.81 |
-0.44 |
-0.14 |
| EPS Diluted |
-1.3 |
-1.72 |
-1.81 |
-0.44 |
-0.14 |
| Weighted Average Shares
Out |
$26.99 M
|
$26.31 M
|
$26.24 M
|
$26.32 M
|
$26.32 M
|
| Weighted Average Shares
Out Diluted |
$26.99 M
|
$26.31 M
|
$26.24 M
|
$26.32 M
|
$26.32 M
|
| Link |
|
|
|
|
|
